Completed OBSERVATIONAL NCT06747026

Real-World Immuno-Radiotherapy for Advanced NSCLC (OCEANUS)

Real-world Survival Outcomes and the Evaluation of Optimal Strategies for Immuno-Radiotherapy in Advanced Non-Small-Cell Lung Cancer: a Territory-wide Study (OCEANUS Study)

Sponsor: Fengming Kong

Conditions Lung Cancer Non-Small Cell Cancer (NSCLC)

Interventions RT after discontinuation of ICI RT with maintenance of ICI initial Concurrent iRT initial Sequential iRT

Updated 2 times since 2025 Last updated: Dec 18, 2024 Started: Jan 1, 2015 Primary completion: Dec 1, 2024 Completion: Dec 1, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06747026, this observational or N/A phase trial focuses on Lung Cancer Non-Small Cell Cancer (NSCLC) and remains completed. Sponsored by Fengming Kong, it has been updated 2 times since 2015, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

2 versions recorded

Sep 2025 — Present [monthly]

Completed
Jan 2025 — Sep 2025 [monthly]

Completed

First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fengming Kong

Data source: The University of Hong Kong-Shenzhen Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hong Kong, Hong Kong